Soolantra better than Metrogel at long term remission


This just-published study finds that once your rosacea is under control, Soolantra once a day will likely do a better job at keeping papules and pustules at bay compared to Metrogel 0.75% twice per day.

Why not Metrogel 1%?

Interestingly this study did not compare Soolantra against Metrogel 1%, but Metrogel 0.75%. The leaves us to wonder if the researchers were wary of cannibalising sales of Metrogel 1% – by only wanting to prove that Soolantra was better than the last generation metronidazole gel based treatment.

Relapse Later, Less Relapsing

Researchers were able to show, that once the papules and pustules of rosacea were brought under control, using Soolantra resulted in a longer period before a relapse occured, and that overall it was less likely for symptoms to return using Soolantra.

Soolantra users took on average 115 days before symptoms returned and Metrogel users took 85 days before papules and pustules returned.

At the end of the study period, that is 36 weeks after rosacea symptoms were at first brought into remission, 62.7% of Soolantra users experienced a relapse, and 68.4% of Metrogel users relapsed. This 5.7% difference in relapse rate is considered a statistically different rate and a positive result for Soolantra.

Adverse events had a similar occurrence between both treatment groups.

Study Backed by Galderma

Many of the study authors have worked directly and indirectly for Galderma, and the study itself was funded by Galderma R&D.

All Good News for Galderma

These sorts of results are great for the marketing machine inside Galderma. One can easily imagine that we might see Soolantra promoted as being the best treatment short term, medium term, long term and now for keeping your rosacea in remission for years to come.

If you are already using Metrogel 1%, then this study won’t prove that switching to Soolantra will improve your long term chances of remission, but may hint you could do better.

Article Abstract

Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study.

J Eur Acad Dermatol Venereol. 2015 Dec 21.

BACKGROUND: There are a limited number of approved treatments for papulopustular rosacea (PPR) and remission is difficult to maintain after successful treatment.

OBJECTIVES: To investigate remission over a 36-week extension period in patients with moderate to severe PPR successfully treated with 16 weeks’ treatment with ivermectin 1% cream once daily (QD) or metronidazole 0.75% cream twice daily (BID) in a randomized, parallel-group Phase III study

CONCLUSION: The results of this relapse study showed that an initial successful treatment with ivermectin 1% cream QD significantly extended remission of rosacea compared with initial treatment with metronidazole 0.75% cream BID following treatment cessation.

Expert Comments

Some expert comments on the clinical relevance of these trial results have been published. Dr. Friedman is generally impressed with the quality of the research and supportive of the idea that Ivermectin 1% is a worthy addition to the rosacea treatment armament.

Expert touts ivermectin 1% cream as treatment of choice for rosacea

… it is rare to see a company structure a superiority head-to-head study, so I will give credit where it is due. However, my guess here is that it was anticipated that ivermectin would at the very least prove noninferior, if not superior, given the poor success rate of this long-standing workhorse.

This should not distract from the fact that a) the studies were thorough and well structured and b) held for a good time frame. The data are certainly compelling, so I don’t want that to be overshadowed by the heavy focus on comparing to metronidazole twice a day. To me, that’s a red herring; had they only compared to placebo, we wouldn’t be having this discussion.

The data herein presented are more than supportive of its addition to our limited armamentarium, but to say first line is premature at this early stage. The once-daily dosing and limited adverse events are supportive features as patient compliance is always an issue. Probably more important, and only time will tell, is will insurance companies cover it? Or, will they reject our prescriptions and continue the current trend of recommending medications that bear no similarity to mechanism of action or efficacy. I am suddenly reminded of the all too frequent notice sent, stating that I should give an acne patient benzoyl peroxide, instead of the retinoid I initially selected.

Kudos to Galderma for keeping innovation alive and bringing a new topical drug forward – curious to see if I can actually prescribe it.

Dr. Adam Friedman

Related Articles


About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

8 Reader Comments

  1. john tissington says:

    I am a mature male Brit and have had Rosacea around 25 years. Tried the lot! Been using Finacea for about 5 years which has kept it down but still quite a lot of spots on the forehead. It recently hasn’t seemed so effective.Recently bought an Obagi daily foaming cleanser recommended for acne and got a prescription for Soolantra and my skin hasn’t been this good for 30 years. The change is remarkable. I look lovely. Well not that good but this is the most radical change for me ever since my first diagnosis. I am so pleased.

    • John Tissington says:

      Just to say 2 years later still the same. Just using the Obadiah foaming cleanser now. Skin as clear as a bell.

      • Christine says:

        Hi John, My fifteen year old grandson has nasty pustules, he’s been on oral antibiotics for a few months , some slow improvement . There is so much information that I feel confused, Could you recommend a treatment for him ?
        I suffer mild rosace including ocular, and I’m concerned for genetics coming through to grandson. Mine has progressed to Rhinophyma

        • John Tissington says:

          I had no family history of Rosacea so I think my situation was very different to the one you describe. All I can say is Soolantra worked for me and maybe being old helped. Still young at heart and skin clear as a bell.

  2. Henry Gaughan says:

    can you use soolantra say at night and finacea during the day.

    • John Tissington says:

      I do have some Finacea left but because the Soolantra is working so well not felt the need to experiment. I posted five months ago and I can honestly say that my skin has never been clearer. I have to be honest and I have no idea whether it is the Obagi cleanser or Soolantra which is doing the job but having tried just about everything else I have ever read about as a remedy this is the only combination which has worked for me.

  3. “Soolantra cleared my rosacea within 8 weeks. I now no longer have to apply at all.. my dermatologist is finding others who also no longer need medication at all. Not to say it can’t come back someday but I have been clear now for almost 2 years. Metro gel did nothing for me.”

  4. “Soolantra has kept me completely clear for 18 months now ”

    “My doctor has me on Aldactone 50mg once a day. Even the redness is gone!”

    “It has helped me some I guess looking back at pictures. It is just so frustursting how red I still am. I have soolantra, azelex, metrogel. And then do doxycycline and another pill orally. All prescriptions. Still not where I want my rosacea to be but it is a lot better than 2 years ago at least.”

    “Great, but it cost hundreds of dollars for a tube. Insurance doesn’t cover it.”

Leave your comment here


Discover more from Rosacea Support Group

Subscribe now to keep reading and get access to the full archive.

Continue reading

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.